Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

Increased Inflammatory Activity in Patients 3 Months after Myocardial Infarction with Nonobstructive Coronary Arteries.

Hjort M, Eggers KM, Lindhagen L, Agewall S, Brolin EB, Collste O, Daniel M, Ekenbäck C, Frick M, Henareh L, Hofman-Bang C, Malmqvist K, Spaak J, Sörensson P, Y-Hassan S, Tornvall P, Lindahl B.

Clin Chem. 2019 May 9. pii: clinchem.2018.301085. doi: 10.1373/clinchem.2018.301085. [Epub ahead of print]

PMID:
31072836
2.

Personality Traits in Patients with Myocardial Infarction with Nonobstructive Coronary Arteries.

Nero D, Agewall S, Daniel M, Caidahl K, Collste O, Ekenbäck C, Frick M, Henareh L, Jernberg T, Malmqvist K, Schenck-Gustafsson K, Spaak J, Sörensson P, Sundin Ö, Y-Hassan S, Hofman-Bang C, Tornvall P.

Am J Med. 2019 Mar;132(3):374-381.e1. doi: 10.1016/j.amjmed.2018.11.010. Epub 2018 Nov 30.

PMID:
30503881
3.

Prevalence of Anxiety and Depression Symptoms in Patients with Myocardial Infarction with Non-Obstructive Coronary Arteries.

Daniel M, Agewall S, Berglund F, Caidahl K, Collste O, Ekenbäck C, Frick M, Henareh L, Jernberg T, Malmqvist K, Schenck-Gustafsson K, Spaak J, Sundin Ö, Sörensson P, Y-Hassan S, Hofman-Bang C, Tornvall P.

Am J Med. 2018 Sep;131(9):1118-1124. doi: 10.1016/j.amjmed.2018.04.040. Epub 2018 Jun 1.

PMID:
29859805
4.

Effect of Myocardial Infarction With Nonobstructive Coronary Arteries on Physical Capacity and Quality-of-Life.

Daniel M, Agewall S, Caidahl K, Collste O, Ekenbäck C, Frick M, Y-Hassan S, Henareh L, Jernberg T, Malmqvist K, Schenck-Gustafsson K, Sörensson P, Sundin Ö, Hofman-Bang C, Tornvall P.

Am J Cardiol. 2017 Aug 1;120(3):341-346. doi: 10.1016/j.amjcard.2017.05.001. Epub 2017 May 10.

PMID:
28610801
5.

Plasma biomarker levels and non-obstructive coronary artery disease determined by coronary computed tomography angiography.

Brolin EB, Agewall S, Cederlund K, Ekenbäck C, Henareh L, Malmqvist K, Rück A, Svensson A, Tornvall P.

Clin Physiol Funct Imaging. 2018 Mar;38(2):246-253. doi: 10.1111/cpf.12407. Epub 2017 Feb 6.

PMID:
28168796
6.

Risk Factors and Markers for Acute Myocardial Infarction With Angiographically Normal Coronary Arteries.

Daniel M, Ekenbäck C, Agewall S, Brolin EB, Caidahl K, Cederlund K, Collste O, Eurenius L, Frick M, Younis-Hassan S, Henareh L, Jernberg T, Malmqvist K, Spaak J, Sörensson P, Hofman-Bang C, Tornvall P.

Am J Cardiol. 2015 Sep 15;116(6):838-44. doi: 10.1016/j.amjcard.2015.06.011. Epub 2015 Jun 25.

PMID:
26251000
7.

Markers of inflammation, endothelial activation, and arterial stiffness in hypertensive heart disease and the effects of treatment: results from the SILVHIA study.

Jekell A, Malmqvist K, Wallén NH, Mörtsell D, Kahan T.

J Cardiovasc Pharmacol. 2013 Dec;62(6):559-66. doi: 10.1097/FJC.0000000000000017.

PMID:
24084214
8.

Myocardial infarction with normal coronary arteries is common and associated with normal findings on cardiovascular magnetic resonance imaging: results from the Stockholm Myocardial Infarction with Normal Coronaries study.

Collste O, Sörensson P, Frick M, Agewall S, Daniel M, Henareh L, Ekenbäck C, Eurenius L, Guiron C, Jernberg T, Hofman-Bang C, Malmqvist K, Nagy E, Arheden H, Tornvall P.

J Intern Med. 2013 Feb;273(2):189-96. doi: 10.1111/j.1365-2796.2012.02567.x. Epub 2012 Aug 5.

9.

Platelet-derived microparticles during and after acute coronary syndrome.

Skeppholm M, Mobarrez F, Malmqvist K, Wallén H.

Thromb Haemost. 2012 Jun;107(6):1122-9. doi: 10.1160/TH11-11-0779. Epub 2012 Feb 28.

PMID:
22371053
10.

Risk factors for myocardial infarction with normal coronary arteries and myocarditis compared with myocardial infarction with coronary artery stenosis.

Agewall S, Daniel M, Eurenius L, Ekenbäck C, Skeppholm M, Malmqvist K, Hofman-Bang C, Collste O, Frick M, Henareh L, Jernberg T, Tornvall P.

Angiology. 2012 Oct;63(7):500-3. doi: 10.1177/0003319711429560. Epub 2011 Dec 29.

PMID:
22210737
11.

Myocardial infarction with angiographically normal coronary arteries.

Agewall S, Eurenius L, Hofman-Bang C, Malmqvist K, Frick M, Jernberg T, Tornvall P.

Atherosclerosis. 2011 Nov;219(1):10-4. doi: 10.1016/j.atherosclerosis.2011.04.036. Epub 2011 May 6. Review.

PMID:
21601856
12.

Is fibrin formation and thrombin generation increased during and after an acute coronary syndrome?

Skeppholm M, Kallner A, Malmqvist K, Blombäck M, Wallén H.

Thromb Res. 2011 Nov;128(5):483-9. doi: 10.1016/j.thromres.2011.03.011. Epub 2011 Apr 14.

PMID:
21496882
13.

[Myocardial infarction with normal coronary arteries in women. MINCA--a specific type of myocardial infarction].

Skeppholm M, Agewall S, Ljungman P, Daniel M, Eriksson M, Hofman-Bang C, Malmqvist K, Reistam U, Svane B, Tornvall P.

Lakartidningen. 2007 Sep 12-18;104(37):2586-8. Review. Swedish. No abstract available.

PMID:
17970392
14.
15.
16.
19.

Compression, adaptation and efferent control in a revised outer hair cell functional model.

Stasiunas A, Verikas A, Bacauskiene M, Miliauskas R, Stasiuniene N, Malmqvist K.

Med Eng Phys. 2005 Nov;27(9):780-9. Epub 2005 Apr 18. Review.

PMID:
16171738
20.
21.

A multi-channel adaptive nonlinear filtering structure realizing some properties of the hearing system.

Stasiunas A, Verikas A, Kemesis P, Bacauskiene M, Miliauskas R, Stasiuniene N, Malmqvist K.

Comput Biol Med. 2005 Jul;35(6):495-510.

PMID:
15780861
22.

Irbesartan and atenolol improve diastolic function in patients with hypertensive left ventricular hypertrophy.

Müller-Brunotte R, Edner M, Malmqvist K, Kahan T.

J Hypertens. 2005 Mar;23(3):633-40.

PMID:
15716707
23.

Single nucleotide polymorphisms predict the change in left ventricular mass in response to antihypertensive treatment.

Liljedahl U, Kahan T, Malmqvist K, Melhus H, Syvänen AC, Lind L, Kurland L.

J Hypertens. 2004 Dec;22(12):2321-8.

PMID:
15614026
24.

Beta1-adrenergic receptor gene polymorphisms and response to beta1-adrenergic receptor blockade in patients with essential hypertension.

Karlsson J, Lind L, Hallberg P, Michaëlsson K, Kurland L, Kahan T, Malmqvist K, Ohman KP, Nyström F, Melhus H.

Clin Cardiol. 2004 Jun;27(6):347-50.

26.

Gender-specific association between preproendothelin-1 genotype and reduction of systolic blood pressure during antihypertensive treatment--results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA).

Hallberg P, Karlsson J, Lind L, Michaëlsson K, Kurland L, Kahan T, Malmqvist K, Ohman KP, Nyström F, Liljedahl U, Syvänen AC, Melhus H.

Clin Cardiol. 2004 May;27(5):287-90.

27.

Transforming growth factor beta1 genotype and change in left ventricular mass during antihypertensive treatment--results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA).

Hallberg P, Lind L, Billberger K, Michaelsson K, Karlsson J, Kurland L, Kahan T, Malmqvist K, Ohman KP, Nyström F, Liljedahl U, Syvänen AC, Melhus H.

Clin Cardiol. 2004 Mar;27(3):169-73.

28.

Blood pressure and left ventricular geometric pattern determine diastolic function in hypertensive myocardial hypertrophy.

Müller-Brunotte R, Kahan T, Malmqvist K, Edner M; Swedish ibesartan left ventricular hypertrophy investigation vs atenolol (SILVHIA).

J Hum Hypertens. 2003 Dec;17(12):841-9.

PMID:
14704728
29.
31.

Adipocyte-derived leucine aminopeptidase genotype and response to antihypertensive therapy.

Hallberg P, Lind L, Michaëlsson K, Kurland L, Kahan T, Malmqvist K, Ohman KP, Nyström F, Liljedahl U, Syvänen AC, Melhus H.

BMC Cardiovasc Disord. 2003 Sep 18;3:11. Epub 2003 Sep 18.

32.

A non-linear circuit for simulating OHC of the cochlea.

Stasiunas A, Verikas A, Kemesis P, Bacauskiene M, Miliauskas R, Stasiuniene N, Malmqvist K.

Med Eng Phys. 2003 Sep;25(7):591-601.

PMID:
12835072
33.
34.

Relationships between left ventricular mass and the renin-angiotensin system, catecholamines, insulin and leptin.

Malmqvist K, Ohman KP, Lind L, Nyström F, Kahan T.

J Intern Med. 2002 Nov;252(5):430-9.

35.

Selecting neural networks for a committee decision.

Verikas A, Lipnickas A, Malmqvist K.

Int J Neural Syst. 2002 Oct;12(5):351-61.

PMID:
12424806
37.

The CYP2C9 genotype predicts the blood pressure response to irbesartan: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA) trial.

Hallberg P, Karlsson J, Kurland L, Lind L, Kahan T, Malmqvist K, Ohman KP, Nyström F, Melhus H.

J Hypertens. 2002 Oct;20(10):2089-93.

PMID:
12359989
38.

Soluble cell adhesion molecules in hypertensive concentric left ventricular hypertrophy.

Malmqvist K, Wallén HN, Held C, Kahan T.

J Hypertens. 2002 Aug;20(8):1563-9.

PMID:
12172318
40.

Influence of age and cardiovascular factors on regional pulsed wave Doppler myocardial imaging indices.

Edner M, Jarnert C, Müller-Brunotte R, Malmqvist K, Ring M, Kjerr AC, Lind L, Kahan T.

Eur J Echocardiogr. 2000 Jun;1(2):87-95.

PMID:
12086213
41.
43.

Angiotensin converting enzyme gene polymorphism predicts blood pressure response to angiotensin II receptor type 1 antagonist treatment in hypertensive patients.

Kurland L, Melhus H, Karlsson J, Kahan T, Malmqvist K, Ohman KP, Nyström F, Hägg A, Lind L; Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) Trial.

J Hypertens. 2001 Oct;19(10):1783-7.

PMID:
11593098
44.

Regression of left ventricular mass with captopril and metoprolol, and the effects on glucose and lipid metabolism.

Malmqvist K, Kahan T, Isaksson H, Ostergren J.

Blood Press. 2001;10(2):101-10.

PMID:
11467759
45.

Regression of left ventricular hypertrophy in human hypertension with irbesartan.

Malmqvist K, Kahan T, Edner M, Held C, Hägg A, Lind L, Müller-Brunotte R, Nyström F, Ohman KP, Osbakken MD, Ostergern J.

J Hypertens. 2001 Jun;19(6):1167-76.

PMID:
11403367
46.

Evaluation of various electrocardiographic criteria for left ventricular hypertrophy in patients with stable angina pectoris: influence of using modified limb electrodes.

Malmqvist K, Kahan T, Eriksson S, Björkander I, Held C, Forslund L, Rehnqvist N, Hjemdahl P.

Clin Physiol. 2001 Mar;21(2):196-207.

PMID:
11318827
47.

Left ventricular mass is not related to insulin sensitivity in never-treated primary hypertension.

Malmqvist K, Isaksson H, Ostergren J, Kahan T.

J Hypertens. 2001 Feb;19(2):311-7.

PMID:
11212975
48.

Left ventricular hypertrophy is associated with an attenuated endothelium-dependent vasodilation in hypertensive men.

Millgård J, Hägg A, Kahan T, Landelius J, Malmqvist K, Sarabi M, Lind L.

Blood Press. 2000;9(6):309-14.

PMID:
11212058
49.
50.

Endothelium-dependent vasodilatation in treated and untreated hypertensive subjects.

Lind L, Millgård J, Sarabi M, Kahan T, Malmqvist K, Hägg A.

Blood Press. 1999;8(3):158-64.

PMID:
10595693

Supplemental Content

Loading ...
Support Center